The Pronutri's CEO talks about his experience with Strategic Challenge, Eurobiomed's new offering, which combines the expertise of its team and network to support members in their healthcare innovation projects.
How did the initial phase of assessing your needs with Eurobiomed go?
Following promising advances in our R&D project on reducing the side effects of chemotherapy, we needed to take a step back. After several exchanges with ventures, we needed a 360° audit to assess the potential value of our work.
Eurobiomed perfectly understood this challenge and proposed Strategic Challenge, an offer adapted to our stage of development.
How did you perceive the complementarity of the experts mobilized for your support?
The support provided was very effective, thanks to a flexible schedule that alternated face-to-face and remote meetings, without being time-consuming.
The strength of the system lies in the selection of two complementary profiles: an expert in the therapeutic field concerning the side effects of chemotherapy, and a former start-up CSO bringing her expertise in scientific valorization. This dual approach enabled us to benefit from both a technical and strategic view of our project.
What were the main benefits of the final deliverable for your company?
The report went far beyond our expectations. In addition to analyzing the stages of development, the experts produced a detailed mapping of the market players, the forces at play and the opinion leaders to approach.
They also presented us with different development scenarios, such as creating a dedicated company or continuing development in-house, detailing the implications of each option. This global vision really enabled us to gain perspective on our project.
